The coronavirus family of positive-strand RNA viruses includes important pathogens of livestock, companion animals, and humans, including the severe acute respiratory syndrome coronavirus that was responsible for a worldwide outbreak in 2003. The unusually complex coronavirus replicase/transcriptase is comprised of 15 or 16 virus-specific subunits that are autoproteolytically derived from two large polyproteins. In line with bioinformatics predictions, we now show that feline coronavirus (FCoV) nonstructural protein 16 (nsp16) possesses an S-adenosyl-L-methionine (AdoMet)-dependent RNA (nucleoside-2O)-methyltransferase (2O-MTase) activity that is capable of cap-1 formation. Purified recombinant FCoV nsp16 selectively binds to short capped RNAs. Remarkably, an N7-methyl guanosine cap ( 7Me GpppAC 3-6 ) is a prerequisite for binding. High-performance liquid chromatography analysis demonstrated that nsp16 mediates methyl transfer from AdoMet to the 2O position of the first transcribed nucleotide, thus converting 7Me GpppAC 3-6 into 7Me GpppA 2OMe C 3-6 . The characterization of 11 nsp16 mutants supported the previous identification of residues K45, D129, K169, and E202 as the putative K-D-K-E catalytic tetrad of the enzyme. Furthermore, residues Y29 and F173 of FCoV nsp16, which may be the functional counterparts of aromatic residues involved in substrate recognition by the vaccinia virus MTase VP39, were found to be essential for both substrate binding and 2O-MTase activity. Finally, the weak inhibition profile of different AdoMet analogues indicates that nsp16 has evolved an atypical AdoMet binding site. Our results suggest that coronavirus mRNA carries a cap-1, onto which 2O methylation follows an order of events in which 2O-methyl transfer must be preceded by guanine N7 methylation, with the latter step being performed by a yet-unknown N7-specific MTase.
The family Coronaviridae, comprising the genera Coronavirus and Torovirus, belongs to the order Nidovirales, a lineage of positive-strand RNA viruses that also includes the Arteriviridae and Roniviridae families (for a review, see reference 28). Coronaviruses (CoV) are frequently associated with respiratory and enteric diseases in humans, livestock, and companion animals. In recent years, they received worldwide attention following both the 2003 outbreak caused by the emerging severe acute respiratory syndrome CoV (SARS-CoV) (17, 43, 57) and the subsequent identification of several other novel family members, including two additional human pathogens (63) . On the basis of antigenic and genetic analyses, CoV have been divided into three groups (29) , with group 3 representing avian CoV and group 2 including viruses like murine hepatitis virus (MHV), the human CoV (HCoV) OC43 and HKU1, and SARS-CoV. CoV group 1 includes, among others, the HCoV 229E and NL63, the porcine transmissible gastroenteritis virus, and canine and feline CoV (FCoV). Infection with FCoV is very common in cats and kittens. Although FCoV infection usually is transient, resulting in a mild gastrointestinal disease, the virus may persist in a significant percentage of cases (1) . A small proportion of FCoV-infected cats develop a lethal, immune-mediated disease that is known as feline infectious peritonitis (FIP). The basis for virulence has remained controversial, with one suggestion being that FIP virus (FIPV) arises when a persistently infecting, enteric FCoV acquires mutations that increase its virulence (81) .
As for other nidoviruses, the large genome of CoV (27 to 32 kb) is polycistronic, with about two-thirds being occupied by two large replicase open reading frames (ORF1a and ORF1b) that encode the viral nonstructural proteins (nsps). The genes downstream of the replicase ORFs encode structural and virus-specific accessory proteins (for a review, see reference 28) . Genome expression starts with the translation of ORF1a and ORF1b, presumably by a cap-dependent mechanism (44, 80) , with the expression of ORF1b involving a Ϫ1 ribosomal frameshift (9) . The two resulting replicase polyproteins, pp1a and pp1ab, are processed by two or three viral proteases to generate 16 end products, termed nsp1 to nsp16 (28, 76, 87) . These cleavage products assemble into a large, membrane-anchored multienzyme complex, termed the replication-transcription complex, that mediates all functions required for genome replication and subgenomic mRNA synthesis (38, 78, 79) . The replication-transcription complex includes enzyme functions commonly found in positive-strand RNA viruses, like an RNAdependent RNA polymerase (nsp12 [13] ), proteases (nsp3 and nsp5 [4, 49] ), and a helicase/RNA triphosphatase (nsp13 [40, 73] ). Additionally, the CoV genome encodes a set of RNAprocessing activities that either are unique to certain nidovirus subgroups or are found in only a few other groups of RNA viruses (76) . These functions include an ADP-ribose phosphatase (X or macro domain in nsp3 [62] ), a recently discovered putative RNA primase (nsp8 [37] ), an exoribonuclease (nsp14 [54] ), and a nidovirus uridylate-specific endoribonuclease (NendoU in nsp15 [39] ).
This group of enzymes also includes the functionally uncharacterized nsp16, which was predicted to be an S-adenosyl-Lmethionine (AdoMet)-dependent RNA (nucleoside-2ЈO)methyltransferase (2ЈO-MTase) (53, 76, 82) . It contains a highly conserved catalytic tetrad (K-D-K-E) that is a hallmark of RNA 2ЈO-MTases (12, 19, 22, 23) . A three-dimensional model of the MTase core of SARS-CoV nsp16 was generated by a structure prediction server (3D jury meta predictor) using the 2ЈO-MTase domain of the reovirus protein 2 as a template (82) . Based on the role of its homologues in other RNA viruses, nsp16 was postulated to be involved in mRNA capping (76, 82) . Alternatively, but not mutually exclusively, it was proposed that nsp16 2ЈO methylates selected nucleosides in virus and/or cellular RNAs as part of a pathway that could involve other unique CoV RNA-processing enzymes (76) . Somewhat compatible with this hypothesis, RNA cleavage by the nsp15 NendoU was found to be inhibited by 2ЈO-methylation (39) . Whereas the exact role of nsp16 during CoV replication still is unknown, its functional importance was supported by mutagenesis experiments using a SARS-CoV replicon system (3) . The deletion of the nsp16 coding sequence blocked RNA synthesis, whereas a single mutation in the catalytic tetrad reduced replicon-driven mRNA synthesis to about 10% of the level for the wild type (wt). Moreover, the phenotype of temperature-sensitive MHV mutants suggested that nsp16 has an essential role in either the synthesis or stability of viral RNA or in controlling a cellular function that is able to limit virus replication (70) . Elucidating the specific biochemical properties of nsp16 clearly would help to assess its role and importance in the viral life cycle.
The RNA cap is a unique structure found at the 5Ј end of eukaryotic cellular and many viral messenger RNAs. In eukaryotic cells, the cap structure protects mRNA from degradation by 5Ј exoribonucleases and enhances the initiation of mRNA translation (24, 75) . For nascent cellular transcripts, the addition of the cap-0 structure is a cotranscriptional event that occurs in the nucleus. Cap-0 formation generally requires three sequential enzymatic activities: (i) an RNA 5Ј-triphosphatase (RTPase) that removes the 5Ј ␥-phosphate group of the mRNA; (ii) a guanylyltransferase (GTase), or capping enzyme, that catalyzes the transfer of GMP to the remaining 5Ј-diphosphate end; and (iii) an AdoMet-dependent (guanine-N7)-MTase (N7-MTase) that methylates the cap at the N7 position. Whereas lower eukaryotes, including yeast, employ a cap-0 structure, higher eukaryotes convert cap-0 into cap-1 or cap-2 structures (46) by means of a nuclear AdoMet-dependent 2ЈO-MTase that methylates the ribose 2ЈO position of the first and second nucleotide of the mRNA, respectively.
Many viruses that replicate in the cytoplasm encode their own RNA capping machinery. Some of these viruses, such as the positive-sense single-stranded RNA (ssRNA) flaviviruses (20, 66) and DNA poxviruses (84) , seem to have adopted the sequential four-step mechanism used in eukaryotic mRNA cap-1 formation. However, the molecular and genetic organization of the enzymatic activities involved in RNA capping varies between virus groups. For example, in the poxvirus vaccinia virus (VV), cap-0 formation is catalyzed by a single 95-kDa protein encoded by viral gene D1 (21, 31, 74, 84) . The subsequent methylation of capped RNA at the 2ЈO position requires VP39, a bifunctional protein that also directs 3Ј polyadenylation (71) . In contrast, in flaviviruses, an RTPase activity is found in the C-terminal domain of the multifunctional helicase protein NS3 (7, 8) , whereas the two MTase activities (the N7-and 2ЈO-MTases) reside in the N-terminal domain of the RNA-dependent RNA polymerase subunit NS5 (19, 66) . There also are RNA viruses with capping mechanisms that deviate dramatically from the canonical pathway. Alphaviruses may use an alternative pathway for mRNA capping, in which the GTP molecule is methylated before being transferred to the 5Ј-diphosphate end of viral RNAs (2) . Yet another unconventional mechanism is employed by the rhabdovirus vesicular stomatitis virus (VSV), which involves a unique polyribonucleotidyltransferase activity to transfer the monophosphate mRNA onto GDP derived from GTP (55) .
CoV not only have a genomic mRNA but also produce an extensive nested set of subgenomic mRNAs, a property that emphasizes the importance of the presumed RNA capping process (for recent reviews, see references 56 and 69). On the basis of T1-oligonucleotide fingerprinting, Lai and Stohlman previously claimed that the 5Ј end of MHV mRNAs carries a cap structure (44) . Moreover, using a cap-specific monoclonal antibody and exoribonuclease protection assays, it was demonstrated that both genomic and subgenomic mRNAs of equine torovirus carry a 5Ј cap (80) . However, the cap structure and the enzymes involved in CoV RNA capping and their mechanisms of action have not yet been characterized. The multifunctional nsp13 helicase subunit possibly is involved, which was previously shown to carry an RNA 5Ј-triphosphatase activity in the case of both group 1 and group 2 CoV (HCoV-229E and SARS-CoV) (40, 41) . As for several other groups of RNA viruses, the GTase involved has not yet been identified. In addition to the predicted nsp16-mediated 2ЈO-MTase activity (76, 82) , it was suggested that the SUD (for SARS-CoV unique domain) of SARS-CoV nsp3 exhibits N7-MTase activity (26) . This prediction, which has not been verified experimentally, is weakened by the fact that this domain is conserved only in group 2b CoV (A. E. Gorbalenya, unpublished data). Thus, the identification of the N7-MTase as well as other CoV capping factors remains to be achieved.
In this paper, we provide the first experimental evidence for the AdoMet-dependent 2ЈO-MTase activity of a CoV nsp16. Using recombinant FCoV nsp16 and short capped and uncapped RNAs, we show that this enzyme has selective RNA binding properties and demonstrate that it is a cap-0 ( 7Me Gp ppAC 5 ) binding protein. Using site-directed mutagenesis, we confirm the essential role of the conserved K-D-K-E catalytic tetrad for mRNA cap 2ЈO-MTase activity and identify aromatic residues in the nsp16 N terminus that may play a key role in cap-0 binding. Finally, the weak inhibition profile of AdoMet analogues that are known potent MTase inhibitors suggests the presence of a unique methyl donor binding site in mM Tris-HCl, pH 7.5, 50 mM NaCl, 2.5% glycerol, 500 g/ml bovine serum albumin (BSA) and stored at Ϫ20°C.
MTase activity assays. Reactions for MTase activity assays were performed in 40 mM Tris-HCl, pH 7.5, 5 mM DTT, 2 M 7Me GpppAC n or GpppAC n, 5 M AdoMet, and 0.03 mCi/ml [ 3 H]AdoMet (GE Healthcare). MgCl 2 was added at a concentration of 1 mM for the standard nsp16 MTase assay. The reducing agent DTT (1 mM) was found to stabilize nsp16 activity over time (data not shown). NS5MTase DV , hN7-MTase, and FCoV nsp16 were added at concentrations of 500 nM, 200 nM, and 3 M, respectively, and reaction mixtures were incubated at 30°C and stopped after 4 h by a 10-fold dilution of the reaction mixture in 100 M ice-cold AdoHcy. Samples were kept on ice and then transferred to glassfiber filtermats (DEAE filtermat; Wallac) by a Filtermat Harvester (Packard Instruments). Filtermats were washed twice with 0.01 M ammonium formate, pH 8.0, twice with water, and once with ethanol, dried, and transferred into sample bags. Betaplate Scint (Wallac) scintillation fluid was added, and the methylation of RNA substrates was measured in counts per minute (cpm) by using a Wallac 1450 MicroBeta TriLux liquid scintillation counter. For inhibition assays, we set up the reaction as described above with a short RNA substrate ( 7Me GpppAC 5 ) in the presence of various concentrations of candidate inhibitors. Enzymes and RNA substrates were mixed with the inhibitor before the addition of AdoMet to start the reaction. The final concentration of DMSO in the reaction mixtures was below 5%, and control reaction mixtures without inhibitor contained corresponding DMSO concentrations. Reaction mixtures were incubated at 30°C for 4 h. The samples then were transferred to glass-fiber filtermats (DEAE filtermat; Wallac) and counted as described above. The IC 50 (inhibitor concentration at 50% activity) value of GTP, 7Me GTP, and AdoHcy were determined using Kaleidagraph. Data were adjusted to a logistic dose-response function, % activity ϭ 100/(1 ϩ [I]/IC 50 ) b , where b corresponds to the slope factor that determines the slope of the curve and [I] corresponds to the inhibitor concentration (15) .
For HPLC analysis, reactions were performed in the absence of [ 3 H]AdoMet, and samples were mixed with 200 l of triethylammonium bicarbonate solution (TEAB) (0.05 M) before HPLC analysis on a Waters model 600 gradient HPLC system. The column assembly consisted of a precolumn (Delta-pak C 18 ; 100 Å, 5 m, 3.9 ϫ 20 mm) and a separation column (Nova-pak C 18 ; 4 m, 3.9 ϫ 150 mm). For the on-line cleaning procedure, both columns were installed in parallel on a 7000 Rheodyne two-valve system (Interchim). Eluent A was a 0.05 M solution of TEAB (pH 7.4), and eluent B was a 1:1 (vol/vol) mixture of acetonitrile (HPLC grade; Carlo Erba SDS, France) and TEAB (final concentration, 0.05 M; pH 7.4). Separations were run at a flow rate of 1 ml/min and started with a 5-min elution (100% eluent A) on the precolumn to remove proteic material. The gradient started after 5 min at 100% eluent A, with an increase to 10% eluent B after 25 min and to 30% eluent B after 45 min.
Analysis of the 7Me GpppAC 5 product by enzymatic digestion and HPLC. A preparative-scale reaction (800 l) was performed using the standard conditions, and the reaction was stopped after overnight incubation. HPLC purification was performed as described above, and peaks corresponding to the reaction products were collected. Lyophilization was repeated three times, and 3 nmol of the reaction products was digested in a 60-l reaction volume containing 50 mM Tris-HCl, pH 8.5, 5 mM MgCl 2 , 0.3 U of nucleotide pyrophosphatase type II from Crotalus adamanteus (0.03 U in a 60-l reaction volume; the enzyme preparation contained phosphodiesterase I side activity; Sigma) and 60 U of calf intestinal phosphatase (New England Biolabs). The digestion was allowed to proceed for 25 min at 37°C and was stopped by being heated to 95°C for 5 min. The digestion products then were separated by HPLC as described previously (58) .
MTase binding assays. Binding assays were performed for 2 h at 4°C in binding buffer (10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 2.5% glycerol, and 500 g/ml BSA) in a total volume of 150 l, as described previously (20) . For competition experiments, incubation mixtures contained increasing concentrations of MgCl 2 , 7Me GTP, GTP, GpppA, or 7Me GpppA. NS5MTase DV and FCoV nsp16 bound to nickel-nitrilotriacetic acid (Ni-NTA) beads were produced as described above. For each experiment, we used 30 l of NS5MTase DV beads (Ϸ4 g/l) and 10 l of 32 P-radiolabeled RNA. Accordingly, 1 nmol of RNA was incubated with beads containing approximately 4 nmol of protein. After three washes with binding buffer, the RNA bound to the beads was liberated using 10 l of formamide-EDTA gel loading buffer and separated by polyacrylamide gel electrophoresis (14% acrylamide-bisacrylamide [19:1], 7 M urea) in TTE buffer (89 mM Tris-HCl, pH 8.0, 28 mM taurine, 0.5 mM EDTA). RNA bands (with the input corresponding to 1/10 or 1/20 of the RNA incubated with NS5MTase DV beads) were visualized using photostimulated plates (fluorescent image analyzer FLA3000; Fuji [11] ), which served as the basis to generate a model using the HHpred server (http://toolkit .tuebingen.mpg.de/hhpred). K45 was added manually using TURBO (68) .
RESULTS
Purified recombinant FCoV nsp16 protein is an AdoMetdependent MTase. The CoV nsp16 previously was predicted to be a 2ЈO-MTase, therefore the enzyme was postulated to participate in cap-1 ( 7Me GpppN2ЈO Me ) formation (76, 82) . To experimentally verify the MTase activity, a cDNA sequence encoding FCoV nsp16 (300 amino acids; FCoV strain FIPV WSU-79/1146 [18] ) was cloned and expressed in E. coli to produce a recombinant nsp16 that was (His) 6 tagged at its N terminus. The protein was purified by immobilized metal affinity chromatography, followed by size-exclusion chromatography in the presence of arginine and glutamate (each at 50 mM) in order to avoid protein precipitation (27) . Upon gel filtration, the protein eluted as a single peak, corresponding to a size of about 65 kDa. In view of the calculated molecular mass of nsp16 and its migration as a single 35-kDa band during SDS-PAGE ( Fig. 1A ), this indicated that the purified protein probably was dimeric in solution. The identity of the recombinant protein was confirmed by matrix-assisted laser desorption ionization-time of flight mass spectrometry after trypsin digestion (data not shown).
To evaluate whether FCoV nsp16 exhibits MTase activity, we first incubated the purified protein with different short capped or uncapped RNA oligonucleotides ( 7Me GpppAC 5 , GpppAC 5 , and pppAC 5 ) in the presence of the radiolabeled methyl donor [ 3 H]AdoMet. The first two nucleotides (AC) of the substrates were identical to the authentic 5Ј-terminal nucleotides of the FCoV genome (5Ј-ACUUUU. . .). As positive controls for MTase activity, we used hN7-MTase and NS5MTase DV (19, 58) . Aliquots of the reaction mixtures were absorbed onto filters and washed, and the radioactivity that remained associated with the RNA substrate was measured to quantify its methylation.
No label was transferred to the uncapped pppAC 5 substrate, using either nsp16 or both control MTases (data not shown). As expected (58), NS5MTase DV shows MTase activity on both capped RNA substrates, whereas hN7-MTase methylated Gp ppAC 5 but not 7Me GpppAC 5 (Fig. 1B) . In contrast, FCoV nsp16 did not catalyze methyl transfer to either the guanine N7 or the 2ЈO position of the GpppAC 5 substrate. However, it was active on the capped 7Me GpppAC 5 substrate and, thus, acted as an AdoMet-dependent mRNA cap MTase (Fig. 1B ). From these observations, we conclude that FCoV nsp16 can transfer a methyl group to the 2ЈO position of the first and/or second nucleotide of an N7-methylated short RNA substrate. A time course experiment using FCoV nsp16 showed that, under our standard assay conditions, substrate accumulation was linear for at least 3 h ( Fig. 1C ) and then reached a plateau after overnight incubation (not shown).
We next characterized several parameters of the FCoV nsp16-mediated MTase activity. An analysis of the pH dependence of the enzyme produced a bell-shaped profile, with maximum activity observed at pH 7.5 ( Fig. 2A ). We also tested the dependence of the MTase on Mg 2ϩ and Mn 2ϩ , since these divalent cations previously were shown to promote O-methylation by some MTases (42) . FCoV nsp16 MTase activity was modulated by the presence of either of the cations Mn 2ϩ (not shown) or Mg 2ϩ (Fig. 2B) , with an optimum around a concentration of 1 mM. Finally, we tested the influence of the chain length of the capped substrate on nsp16 MTase activity. The protein was incubated with a variety of substrates, which differed in the number of cytidines at their 3Ј ends ( 7Me Gppp AC n , where n ϭ 1 to 7), and [ 3 H]AdoMet for 4 h at 30°C. The nsp16-mediated methylation of RNA substrates again was measured using a filter binding assay. Figure 2C reveals a correlation between substrate length and MTase activity. The MTase activity increased with substrate length between 2 and 5 nucleotides (n ϭ 1 to 4) and then reached a plateau. In order to exclude that the observed differences are due to the incomplete retention of small substrates on the filters used, the data were verified using HPLC analysis. To this end, nsp16 was incubated overnight with RNA and AdoMet, and the reaction products were separated by reverse-phase HPLC as described previously (58) . The results were similar to those shown in Fig.  2C (data not shown). We conclude that, under the experimental conditions employed here, FCoV nsp16 exhibits the highest MTase activity at pH 7.5, in the presence of 1 mM Mg 2ϩ , on capped RNA substrates of the 7Me GpppAC n type, where n equals at least four.
FCoV nsp16 targets the 2O position of the first transcribed nucleotide to produce a cap-1 structure. In order to identify the position(s) at which FCoV nsp16 methylates the 7Me Gpp pAC 5 RNA substrate, we analyzed the reaction products by reverse-phase HPLC as described previously (58) . As a control, we included NS5MTase DV , which has been shown by mass spectrometry to methylate this substrate at the 2ЈO position of the first nucleotide (adenosine) and not onto downstream nucleotides (58) . The retention time of the 7Me GpppAC 5 substrate was 29.7 to 29.8 min (Fig. 3A) . Two additional peaks appeared when the reaction products of FCoV nsp16 were analyzed: one was clearly ahead of the AdoHcy reaction product, probably being a degradation product of the latter, and the other had a retention time of 33.9 min (Fig. 3C ). These two peaks, but not the one corresponding to the substrate, also were observed among the products generated by NS5MTase DV , indicating that this enzyme methylated its substrate completely to yield 7Me GpppA 2ЈOMe C 5 (58) , which eluted at 33.9 min (Fig. 3B) . These results indicated that both enzymes catalyzed strictly the same reaction on this capped RNA, albeit with different efficiencies.
The study of the cap structure was further refined as follows. We collected the 33.9-min peak material, digested it enzymatically to release the corresponding nucleosides, and analyzed the resulting mixture using HPLC (Fig. 3D , lower chromatogram). The comparison to standard nucleosides (upper chromatogram) indicated that all adenosines present in the reaction product were methylated at the 2ЈO position. Two additional peaks (3.7 and 7.4 min) also were observed, with the major one (3.7 min) corresponding to unmethylated C and the minor one (7.4 min) remaining ambiguous, corresponding to . The cpm were normalized (100% corresponds to 7Me Gpp pAC 7 ) , and standard deviations were calculated from four independent experiments.
VOL. 82, 2008 2ЈO-METHYLTRANSFERASE ACTIVITY OF FCoV nsp16 8075 on March 15, 2015 by guest http://jvi.asm.org/ 7Me G or a mixture of 7Me G and C 2ЈOMe . We then performed a stoichiometric analysis of the cap components using the respective molar ratio corresponding to each nucleobase peak. The measured peak area (measured with the HPLC diode array detector) was divided by the molar extinction ε at 260 nm that corresponded to each nucleoside (C ϭ 7,200, G ϭ 11,500, 7Me G ϭ 10,100, and A 2ЈOMe ϭ 15,400). The relative molar ratios were found to be 0.82:1:6.2 for 7Me G, A 2ЈOMe , and C, respectively. A cap-1 should yield ratios of 1:1:5, and a cap-2 in which 7Me G comigrates with C 2ЈOMe should yield 2:1:4. Taken together, these results demonstrate that FCoV nsp16 carries a 2ЈO-MTase activity that is capable of converting a cap-0 to a cap-1 RNA structure. N7-methylated guanine of the cap structure is a binding determinant of FCoV nsp16. To gain insight into the mechanism of nsp16-mediated methylation, its binding to various substrates was analyzed. We conducted in vitro binding studies with small capped or uncapped RNAs of various lengths, with or without a methyl group at the N7 position. Using the T7 DNA primase system (58), short ␣-32 P-radiolabeled oligonucleotides were produced carrying 7Me Gppp, Gppp, or ppp at their 5Ј ends. These RNAs were incubated with either FCoV nsp16 or NS5MTase DV immobilized on Ni-NTA beads. After being incubated and washed, RNAs bound to the beads were resolved by PAGE and detected by autoradiography. As illustrated in Fig. 4A , empty control beads bound little of the tested RNAs. In contrast, specific RNAs were retained by the different MTase-carrying Ni-NTA beads. NS5MTase DV efficiently bound RNAs irrespective of their N7 methylation status ( 7Me GpppAC [4] [5] [6] or GpppAC 4-6 ) but did not bind uncapped pppAC [2] [3] [4] [5] [6] RNA. In contrast, FCoV nsp16 exclusively bound capped RNAs that had a methyl at the cap N7 position ( 7Me G overnight with FCoV nsp16. The peak eluting at 33.9 min was collected and digested with a mixture of nucleotide pyrophosphatase, phosphodiesterase I, and calf intestine phosphatase. (D) HPLC chromatogram of digestion products analyzed without the on-line cleaning procedure (lower chromatogram) compared to a mixture of standard compounds (upper chromatogram). The gradient started after 5 min at 100% eluent A, with an increase to 10% eluent B after 25 min and to 30% after 45 min. Absorbances (AU) were measured at 260 nm. pppAC [3] [4] [5] [6] ). Binding depended on RNA size, since capped RNAs with one or two 3Ј-terminal cytidines ( 7Me GpppAC 1-2 ) did not bind efficiently to FCoV nsp16. Thus, requirements for efficient binding to nsp16 matched those favoring the MTase activity of the enzyme (compare Fig. 1B and 2C ). We conclude that FCoV nsp16 specifically binds cap-0-bearing RNAs of at least 4 nucleotides in length. Both the RNA chain and the N7-methyl cap contribute to binding, but the presence of the latter is a prerequisite for binding. This substrate specificity is reminiscent of that of the VV 2ЈO-MTase VP39 (48) but quite different from that of the DV NS5MTase, which recognizes methylated and unmethylated capped RNA equally well ( Fig.  4A and reference 19 ) and harbors both N7-and 2ЈO-MTase activities in a single peptide chain (66) .
Since these results pinpointed nsp16 as a specific cap-0 binding protein, we sought to determine whether 7Me GTP, GTP, or 7Me GpppA could interfere with the binding of capped RNA, as previously shown for NS5MTase DV (20) . To this end, we incubated nsp16-Ni-NTA beads with 7Me GpppAC 3-6 and measured their binding capacity in the presence of an increasing concentration of GTP, 7Me GTP, or 7Me GpppA. Figure 4B shows that neither GTP nor 7Me GTP (tested at up to 20 mM) had a clear effect on the interaction between nsp16 and RNA. The binding was slightly inhibited by 7Me GpppA, starting at 10 mM. The binding of 7Me GpppAC 3-6 also was not affected by an increasing concentration of Mg 2ϩ , which was shown to stimulate nsp16 MTase activity (Fig. 2B) . Thus, Mg 2ϩ ions were not essential for substrate recognition, and 7Me GTP and 7Me GpppA were poor competitors for binding. The latter property was consistent with the fact that 7Me GpppA could not efficiently serve as a substrate for nsp16. The VV VP39 2ЈO-MTase activity was not inhibited by 7Me GTP or 7Me GpppA (6) . Interestingly, our nsp16 data contrast with the previously reported inhibition of the binding of NS5MTase DV to 7Me GpppAC [3] [4] [5] [6] or GpppAC 3-6 by GTP and 7Me GTP (20) . We conclude that the substrate binding site of the FCoV nsp16 MTase has a complex organization and interacts specifically with both cap-0 and nucleotides downstream of the RNA cap structure.
Inhibition of FCoV nsp16 2O-MTase activity by AdoMet and GTP analogues. Since viral capping enzymes are interesting targets for antiviral therapy (61, 85, 86) , we screened potential inhibitors of FCoV nsp16 MTase activity, starting with AdoMet/AdoHcy and GTP analogues, which previously were identified as inhibitors of AdoMet-dependent MTases (45, 51, (59) (60) (61) . We first addressed whether GTP or 7Me GTP could inhibit 2ЈO-MTase activity. For this purpose, nsp16 was incubated with 7Me GpppAC 5 and [ 3 H]AdoMet in the presence of increasing 7Me GTP or GTP concentrations, and the incorporation of label in methylated RNA was measured using the filter binding assay. Surprisingly, although GTP and 7Me GTP were unable to block the binding of nsp16 to its substrate even at 20 mM (Fig. 4B ), we observed that both nucleotides inhibited MTase activity significantly, yielding IC 50 values of 1.51 Ϯ 0.11 and 1.25 Ϯ 0.12 mM, respectively (Fig. 5A ). This observation suggests that these nucleotides do not act purely as competitive inhibitors of substrate binding. They might interfere with the binding of a specific part of the RNA substrate while leaving the overall binding unchanged.
Using the same assay, we next tested whether FCoV nsp16 was inhibited by a fixed (100 M) concentration of different GTP analogues, AdoMet, and the AdoHcy by-product of the methylation reaction (Fig. 5B ). All tested compounds, including AdoHcy, which is known to be a potent inhibitor of the MTase family (6, 61) , proved to be poor inhibitors of the MTase activity. The IC 50 of AdoHcy was 144 M (Fig. 5C ), approximately 100-fold higher than the concentrations commonly required to inhibit other MTases (6, 61) . Likewise, sinefungin, which previously was shown to be a potent inhibitor of the MTases of Newcastle disease virus and VV (IC 50 values of 150 and 75 nM, respectively [60] ), was found to be a very poor inhibitor for FCoV nsp16. Thus, we conclude that nsp16, unlike its distant viral homologues, can efficiently discriminate AdoMet and its analogues, suggesting that although various AdoMet-dependent MTases share a similar structural organization (see below), nsp16 evolved a specific variant of the conserved AdoMet binding site.
Identification of key residues for FCoV nsp16 2O-MTase activity and substrate binding.
To identify residues involved in catalysis and substrate binding, we engineered and characterized a set of FCoV nsp16 point mutants. The positions to be mutated were selected using a comparative analysis of nsp16 and other, better characterized MTase homologues. We started from a structure-based sequence alignment of four RNA 2ЈO-MTases with known tertiary structures. These enzymes of viral and cellular origin were aligned with nsp16 of SARS-CoV and FCoV, and for the latter a secondary structure prediction was generated (Fig. 6A ). Due to the considerable divergence of the protein sequences used, only limited conservation is evident in the alignment, in particular in regions corresponding to the MTase core, which is structurally conserved among AdoMet-dependent MTases (14, 52) . In line with the original analysis of CoV nsp16 (76, 82) , four out of six invariant residues in the alignment correspond to the K-D-K-E catalytic tetrad of RNA 2ЈO-MTases (12, 19) . These four residues (K45, D129, K169, and E202 in FCoV) were selected for mutagenesis. To identify other potentially important residues, the tertiary organization of the FCoV nsp16 MTase core was modeled through different Web servers (see Materials and Methods). Although the VP39 and FCoV nsp16 MTases share the same binding specificity for cap-0 structures, they were found to be too divergent for any server to produce a meaningful nsp16 model. The closest template proposed by several servers was the rRNA 2ЈO-MTase FtsJ (11) , which therefore was used to model FCoV nsp16 using HHpred (77) . An inspection of the final model (Fig. 6B ) of the MTase core of nsp16 (residues K45 to G221) and other MTase structures ( Fig. 6C and D) showed that in all structures but that of VP39, the spatial equivalent of FCoV nsp16 residue D113 (conserved in CoV nsp16) is also an Asp residue (11, 19) , which is located close to the AdoMet. Therefore, residue D113 of FCoV nsp16 was selected for mutagenesis.
The identification of residues that might be involved in substrate binding was less straightforward. Our starting point was the observation that VV VP39 shares with nsp16 a high specificity for the cap-0 structure. In the structure of VP39 complexed with a 7Me G-capped RNA (Fig. 6C) (33) , the methylated base is stacked between two aromatic side chains (Y22 and F180) ( Fig. 6A and C) . Moreover, in VP39 the methyl group is in contact with residue Y204 (Fig. 6A and C) via van der Waals interactions (33, 64) . Finally, the carboxyl groups of on March 15, 2015 by guest http://jvi.asm.org/ residues D182 and E233 form hydrogen bonds to the NH and NH2 of the guanosine in VP39. Most of these residues are located in regions for which the counterparts in the FCoV nsp16 could not be modeled by HHpred. The only exception was the loop region immediately downstream of ␤-strand 6, in which we selected residues F173 and W175 for mutagenesis, as they are a putative counterpart of VP39 F180 (Fig. 6B ). To probe for cap binding residues in the most divergent N-and C-terminal regions, we limited our selection to residues conserved in CoV that are physicochemically similar to those involved in substrate recognition in VP39. Aromatic residues W4, Y14, and Y29 in the nsp16 N terminus were selected as putative equivalents of Y22 and Y204 in VP39 and residues D221 and D247 in the nsp16 C terminus (Fig. 6A) as candidates for the role of E233 in VP39.
Of the 12 nsp16 mutants engineered, all but W175A were expressed at a level sufficient to allow the purification of the enzyme by our two-step procedure. Consequently, W175A could not be analyzed further. Both their 7Me GpppAC 5 binding capacity and their MTase activity on capped RNA oligonucleotides ( 7Me GpppAC 5 and GpppAC 5 ) were compared to those of the wt control ( Fig. 7) . For none of the mutants was there a change in the dependence on a N7-methylated cap or the selectivity compared to that of an unmethylated cap (Fig.  7A ). The MTase activity was abolished or severely reduced by all mutations affecting the putative K-D-K-E catalytic tetrad, supporting their structure-based assignment as being functionally essential (Fig. 6A ). One of these mutations (K45A) also abolished the binding of capped RNA (Fig. 7C) , while mutations at three other positions reduced it to 20 to 50% of the level observed for the wt protein. This result indicated that K45, and possibly other catalytic residues, contribute to the specific recognition of cap-0 RNA. In the case of D113, which may be part of the predicted AdoMet binding pocket, replacement by Ala reduced 2ЈO-MTase activity to about 10% of the wt level without an apparent effect on substrate binding. In contrast, Ala replacements of the aromatic residues located in the N-terminal subdomain (Y14 and Y29) and downstream of ␤-strand 6 (F173) also reduced the binding of nsp16 to its substrate to 10 to 20% of the wt level (Fig. 7C) . The effects on the MTase activity varied considerably, from complete inhibition (Y29A) to a modest 50% reduction (F173A) or a minor ϳ18% drop (Y14A). Mutations W4A, D221A, and D247A formed a group in which the effect of replacement by Ala on both RNA binding and 2ЈO-MTase activity was comparable, ranging from no change to 55% inhibition at most.
We conclude that the FCoV nsp16 2ЈO-MTase employs the canonical K-D-K-E catalytic tetrad that consists of K45, D129, K169, and E202. Residue D113 also may contribute to catalysis but not to RNA binding. Two residues (K45 and Y29) for which mutagenesis severely compromised both MTase activity and substrate binding may be involved in both substrate recognition and catalysis or, alternatively, only in the specific recognition of cap-0 RNA.
DISCUSSION
Upon CoV infection, replicases ORF1a and ORF1b of the positive-strand RNA genome are translated, presumably by using a cap-dependent mechanism (44, 80) . Although the cap is expected to be essential for ribosome binding and efficient viral mRNA translation (24, 75) , the RNA capping mechanism of CoV is essentially uncharacterized. It supposedly involves four enzymatic activities (24) , including an RTPase (40, 41) , a GTase, and two MTase activities.
The ORF1b-encoded replicase subunits of CoV (nsp12 to nsp16) include five RNA-processing enzymes that have uniquely segregated in the genomes of CoV and other large nidoviruses (28, 76) . In recent years, the activities of four of these enzymes, but not the nsp16 MTase, were characterized for one or more CoV. In this report, we document the MTase activity of nsp16, the C-terminal subunit of the CoV replicase. FCoV nsp16 specifically and selectively binds capped RNAs of 3 to 6 nucleotides in length that carry a methyl group at the N7 position of the guanosine cap, a chemical entity known as the cap-0 structure ( 7Me GpppAC [3] [4] [5] [6] ). FCoV nsp16 catalyzes the transfer of a methyl group from the AdoMet donor to short capped RNAs, but only when they carry a methyl group at the N7-guanine position.
Different 2ЈO-MTases were reported to target either the first (71, 72) or subsequent transcribed nucleotides of capped RNAs (32) . We have identified the methylation position using an enzymatic digestion of the reaction products in conjunction with HPLC analysis. The latter demonstrated that the nsp16 MTase targets the 2ЈO position of the first nucleotide, thus converting 7Me GpppAC n into 7Me GpppA 2ЈOMe C n . Thus, FCoV nsp16 belongs to the family of AdoMet-dependent mRNA cap 2ЈO-MTases that specifically methylates the first endogenous nucleotide of the cap-0 structure to produce a cap-1 structure. These findings support the proposed involvement of nsp16 in CoV translational control (76, 82) and the suggestion that CoV mRNAs carry a cap structure (44, 80) . A more extensive analysis of nsp16 is required to verify whether this enzyme also methylates other nucleotides in virus and/or cellular RNAs to regulate other processes in cooperation with virus RNA-processing enzymes, as proposed previously (76) . With these findings, two of the four cap-forming enzyme functions now have been reported for CoV: an RTPase activity was mapped to the multifunctional nsp13 helicase protein of HCoV 229E (41) and SARS-CoV (40) and the 2ЈO-MTase activity reported here for FCoV nsp16.
Our finding that the FCoV nsp16 2ЈO-MTase strongly prefers substrates carrying a cap-0 structure over those that have a nonmethylated cap indicates that cap maturation in CoV follows the canonical order of methylation steps that have been described for other biological systems. This will have to be compared to the cap methylation recently documented for flaviviruses, in which the NS5 MTase recognizes both methylated and nonmethylated cap structures (this work and reference 20) and catalyzes the methylation of both the N7 position of the guanine as well as the 2ЈO position of the nucleotide ribose (66, 86) . It is possible that nsp16 also possesses N7guanine MTase activity in the presence of longer substrates, e.g., RNA sequences and/or structures specific for the 5Ј-untranslated region of the viral genome. For example, the specificity of the West Nile virus (WNV) NS5MTase for WNVspecific RNA sequences recently was reported (16, 66) . If such a dependence exists in the case of CoV, RNA sequences downstream of the cap structure might represent regulatory elements inducing specific N7 or 2ЈO-methylation events. Residues potentially involved in substrate binding and the methyl transfer reaction were probed by mutagenesis. In addition to the catalytic tetrad K-D-K-E, residue D113 of the AdoMet binding site and residue Y29 are essential for 2ЈO-MTase activity. Similar results were reported recently for the WNV MTase. Using alanine-scanning mutagenesis, it was shown that its K-D 146 -K-E catalytic tetrad is essential for 2ЈO methylation activity, whereas the N7-MTase activity depends mainly on D 146 (86) . The catalytic residues are adequately positioned in the three-dimensional structural model of FCoV nsp16 (Fig. 6B) . Interestingly, we noted that some residues of the catalytic tetrad also are important for the efficient binding of the capped RNA substrate. This observation suggests that the binding of cap RNA involves multiple contact regions. Accordingly, binding assays revealed that a shorter cap-1-containing RNA, 7Me GpppAC 1-2 , did not bind to FCoV nsp16, whereas longer molecules did. The more efficient binding of longer RNAs suggests that the presence of nucleotides downstream from the cap binding site is necessary to stabilize the interaction between FCoV nsp16 and its RNA substrate. This also was confirmed by the poor inhibition of binding observed in the presence of increasing concentrations of 7Me GpppA cap analogue and 7Me GTP. In particular, the K45A substitution was quite spectacular in terms of its effect on both MTase activity and RNA binding. A single nsp16 point mutation abolishing RNA binding is remarkable. Indeed, 7Me GpppAC 5 should interact with many residues of the enzyme, each contributing moderately to RNA binding. Could K45 be an essential residue responsible for specific cap recognition? The superimposition of the VP39 and nsp16 models shows that the methylated guanosine cap binding site is remote from K45 ( Fig. 6B and C ), suggesting that K45A has a drastic indirect effect on the putative RNA binding groove but not a direct effect on the binding of the methylated cap. In contrast, the fact that D113A did not influence substrate binding is consistent with its specific position within the putative AdoMetbinding site. The corresponding residue in NS5MTase DV is located on the side of the AdoMet cofactor, not adjacent to the positively charged, putative RNA-binding groove (20) .
Our mutagenesis study confirmed a contribution of at least one aromatic amino acid to the specificity of methylated cap recognition. Since Y29A abolished both cap-0 recognition and the 2ЈO-MTase activity of FCoV nsp16, we propose that this residue plays an essential role in specific cap recognition through a stacking interaction with cap-0 RNA, which in turn might allow the correct positioning of capped RNA into the catalytic site. Unfortunately, Y29 could not be visualized in the structural model. In contrast, the Y14A and F173A replacements did not reduce 2ЈO-MTase activity as extensively as they inhibited RNA binding. This observation may be explained by the stringent washing conditions in our binding assay and suggests that both residues contribute to cap recognition. The cap binding site of the VV VP39 MTase previously was shown to depend on two aromatic side chains (Y22 and F180) that are necessary to recognize the cap-0 structure by stacking interactions (35) , and the replacement of F180 drastically inhibited 2ЈO-MTase activity (36) . If we assume that a cap binding site is located in the same area in both FCoV nsp16 and VV VP39, F173 is adequately positioned in the three-dimensional model of nsp16 (Fig. 6B) to bind to the cap-0 structure. Therefore, we hypothesize that FCoV nsp16 stacks the methylated guanine moiety of the cap-0 structure between two aromatic residues, similarly to what was found for VV VP39 and the mammalian cap binding translation initiation factor eIF4E (32, 35, 64) . As the most likely candidates for this role, we propose residues Y29 and F173 without formally excluding Y14.
Virus-encoded RNA cap 2ЈO-MTase activities previously have been identified for various other virus genera, such as poxviruses (VP39 [71, 72] ), the double-stranded reoviruses (50, 65) , minus-strand ssRNA viruses such as VSV (47) , and positive-strand ssRNA viruses like flaviviruses (NS5MTase [19, 58, 86] ). The exact role of mRNA cap 2ЈO-methylation in the virus life cycle is still an open question. It is likely that this function confers a replicative advantage on the virus, since 2ЈO-MTases are widely conserved among viruses that have cap-bearing genomes and/or mRNAs. For the WNV MTase, it has been shown that mutations abolishing the N7 and/or 2ЈO-MTase activity have a detrimental effect on the replication of a luciferase-expressing RNA replicon (66) . In contrast, when viral replication was tested directly, a substitution inactivating the N7-MTase activity substantially attenuated replication, whereas 2ЈO-MTase knockouts had more moderate effects (66, 86) . These observations suggest that compounds specifically inhibiting cap-methylating enzymes, either N7-MTase or 2ЈO-MTase or both, could act as potent antiviral agents. Accordingly, a series of AdoMet analogues containing modifications of the nucleoside moiety showed potent and selective antiviral activity against herpes simplex virus, VV, and VSV (5, 61) . In the mRNA MTase domain I of reovirus (Reov) 2 (67). The alignment was generated manually using Seaview (25) and was presented with the ESPript program (30) . The positions of conserved residues are highlighted by a red background, and the regions outlined in blue indicate high sequence similarity (Ͼ70%). The secondary-structure elements of the VP39 and NS5Mtase DV structures and their names are given below the alignment. The predicted FCoV nsp16 secondary structure generated by the PSIPRED protein structure prediction server (10) is indicated above the alignment. The position of the mutations characterized in this study are indicated by triangles above the FCoV nsp16 sequence: salmon triangles for the putative cap-0 binding site, light blue/turquoise for the catalytic site, and yellow for the AdoMet binding site. The conserved catalytic active-site residues K-D-K-E of RNA 2ЈO-MTases are annotated by blue stars, and the VP39 residues participating in cap recognition are indicated with salmon circles. Also shown are the structural comparative analyses of viral Mtases. (B) Ribbon representation of the FCoV nsp16 model as generated on the basis of the structure of rRNA 2ЈO-MTase FtsJ (see Materials and Methods). AdoMet was placed by the superimposition of the FCoV nsp16 model and the structure of rRNA 2ЈO-MTase FtsJ in complex with the cofactor. Structures of VP39 (PDB ID 1AV6) (C) and NS5MTase DV (PDB ID 1L9K) (D) also are shown. A yellow stick representation is used to show AdoMet and the reaction product AdoHcy, with oxygen in red and nitrogen in blue. The side chains and carbon backbone of conserved catalytic residues K-D-K-E are represented by sticks in blue/turquoise (K45 was manually added in the FCoV nsp16 model). The lateral chain of nsp16 D113, which is involved in AdoMet binding, is shown in yellow. The VP39 side chains of residues involved in the binding of the 7Me G cap are represented in salmon, and the cap analogues are in light gray. VOL. 82, 2008 2ЈO-METHYLTRANSFERASE ACTIVITY OF FCoV nsp16 8081 this study, we tested whether some of these AdoMet analogues (e.g., sinefungin, which has an IC 50 of 39 nM for VV VP39 [60] ) would block nsp16 MTase activity, but all of the molecules tested proved to be weak inhibitors. Our observations suggest that the CoV nsp16 MTase is a unique enzyme: it shares its structural organization and specificity for the cap-0 structure with VV VP39, but the divergence of the structurally conserved AdoHcy binding site results in unusually weak inhibition profiles for AdoMet analogues. Furthermore, nsp16 has evolved a unique substrate binding site that cooperates with the canonical catalytic tetrad that is conserved in other 2ЈO-MTases to recruit its substrate. Finally, despite the inability of GTP and 7Me GTP to block cap-0 binding, both nucleotides inhibit FCoV nsp16 activity at similar concentrations, suggesting that the nucleotide binding site is distinct from the site binding the methylated cap. Further functional and structural exploration of FCoV nsp16 will be necessary to define this putative binding site, which is of potential interest for inhibitor design. FIG. 7 . Alanine-scanning mutagenesis of the FCoV nsp16. Activity and substrate binding of FCoV nsp16 mutants. (A) Equal amounts of the different nsp16 mutants were incubated with GpppAC 5 and 7Me G pppAC 5 in the presence of [ 3 H]AdoMet. The methyl transfer to the RNA substrate was monitored during a 240-min time course experiment and detected using a filter binding assay that measured the amount of radioactivity, in cpm, that was transferred to the RNA substrates. MTase activity of 100% was arbitrarily attributed to the wt nsp16 activity when using the 7Me GpppAC 5 substrate. The bar graph presents the results of three independent experiments. (B) The purified nsp16 mutants after separation on SDS-12% Page and Coomassie blue staining. (C) The binding of 7Me GpppAC 5 to nsp16 mutants was determined as described in the legend to Fig. 4 . Binding data were normalized (100% corresponds to 7Me GpppAC 5 bound to wt nsp16).
